Literature DB >> 3936217

Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause.

L Balleisen, J Bailey, P H Epping, H Schulte, J van de Loo.   

Abstract

The Münster Arteriosclerosis Study (MAS) is a prospective, longitudinal epidemiological study on an industrial population in Westfalia aimed to establishing clinical and laboratory data with possible relationship to cardiovascular events. The data presented here describe the baseline measurements of fibrinogen, factor VIIc and factor VIIIc from the recruitment of 2880 male and 1306 female persons and their relationship to age, gender, bodyweight, smoking, alcohol, pill-using and menopause. The correlations were made by means of a multiple regression analysis. We found an increase of those coagulation factors with age, a correlation of F VII and fibrinogen with body-weight index and of fibrinogen with cigarette smoking. No correlation was found for alcohol consumption. F VIII and F VII were significantly higher after onset of menopause and F VII and fibrinogen in women using the pill.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936217

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  35 in total

Review 1.  Percutaneous coronary intervention in the elderly.

Authors:  Tracy Y Wang; Antonio Gutierrez; Eric D Peterson
Journal:  Nat Rev Cardiol       Date:  2010-12-07       Impact factor: 32.419

2.  A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Authors:  Kevin R Viel; Deepa K Machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan C Souto; Juan M Peralta; Todd Smith; John Blangero; Sandra Porter; Stephen T Warren; Jordi Fontcuberta; Jose M Soria; W Dana Flanders; Laura Almasy; Tom E Howard
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

3.  Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study.

Authors:  L Poller; P K MacCallum; J M Thomson; W Kerns
Journal:  Br Heart J       Date:  1990-04

4.  Aging accelerates endotoxin-induced thrombosis : increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging.

Authors:  Koji Yamamoto; Takayoshi Shimokawa; Hong Yi; Ken-ichi Isobe; Tetsuhito Kojima; David J Loskutoff; Hidehiko Saito
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers.

Authors:  A E Thomas; F R Green; H Lamlum; S E Humphries
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

Review 6.  Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients.

Authors:  M T Nurmohamed; H R Büller; J W ten Cate
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

7.  Does weight loss reduce plasma fibrinogen?

Authors:  E Ernst
Journal:  Br Heart J       Date:  1993-08

8.  Genotype-phenotype relationship of F7 R353Q polymorphism and plasma factor VII coagulant activity in Asian Indian families predisposed to coronary artery disease.

Authors:  Jayashree Shanker; Ganapathy Perumal; Arindam Maitra; Veena S Rao; B K Natesha; Shibu John; Sridhar Hebbagodi; Vijay V Kakkar
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 9.  Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women.

Authors:  L R Wiseman; D McTavish
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

10.  Hemostasis and ageing.

Authors:  Daniela Mari; Giulia Ogliari; Davide Castaldi; Giovanni Vitale; Elisa Mariadele Bollini; Domenico Lio
Journal:  Immun Ageing       Date:  2008-10-23       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.